Impact of ferric carboxymaltose therapy on renal function in patients with chronic heart failure and anemia

Back

HFA Premium Access

Impact of ferric carboxymaltose therapy on renal function in patients with chronic heart failure and anemia

Session: Complex comorbidities and heart failure

Topic: Comorbidities

Speaker: Doctor G. Armentaro (Catanzaro, IT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Giuseppe Armentaro

Azienda Ospedaliera Renato Dulbecco, Catanzaro (Italy)

1 presentation

0 follower

4 more presentations in this session

Clinical course of atrial fibrillation patients with and without history of takotsubo syndrome: a propensity matched analysis from the GEIST and ATHERO-AF registries

Speaker: Doctor L. Arcari (Rome, IT)

Elderly satelia surveillance in heart failure (ElderSAT-HF): predictive factors of events after discharge of cardiogeriatric unit

Speaker: Doctor R. Esser (Versailles, FR)

Unravelling the ugly truth about sleep apnea and advanced heart failure: a real-world setting

Speaker: Doctor P. Bernardes (Setubal, PT)

A formidable combination: chronic kidney disease and the under-prescription of guideline directed medical therapy for heart failure

Speaker: Doctor O. Graham (Craigavon, GB)

Access the full session

Complex comorbidities and heart failure

Speakers: Doctor G. Armentaro, Doctor L. Arcari, Doctor R. Esser, Doctor P. Bernardes, Doctor O. Graham

Access

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources